Internet
Rye, New York, 10573, United States
Location status: Recruiting
Location contact
Janaela Scott
CONTACT
Nina Logan, MD
CONTACT
Nina Logan, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07173322
As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rye, New York, 10573, United States
Location status: Recruiting
Janaela Scott
CONTACT
Nina Logan, MD
CONTACT
Nina Logan, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
less than 18 years old.
-
Time frame: data will be collected for 1 year
As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS, in collaboration with John Ligon MD and Citizen Health, has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.
Contact information is provided by the study sponsor or research team.
Brian Chadwick, RN MS
CONTACT
Janaela Scott
CONTACT
844-696-7228 (24 hours)
Blood Cancer United
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724535
Cancer, Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT05754801
Cancer, Neoplasms
Hong Kong
View Trial DetailsNCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial DetailsNCT05350761
Cancer, Environment
Bethesda, Maryland, United States
View Trial Details